• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Request Free Sample ×
    ReportInfographic

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    US Needle free diabetes care Market

    ID: MRFR/MED/17918-HCR
    100 Pages
    Garvit Vyas
    September 2025

    US Needle Free Diabetes Care Market Research Report –Forecast 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    US Needle free diabetes care Market Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Compare License
    Table of Contents

    US Needle free diabetes care Market Summary

    The US Needle Free Diabetes Care market is projected to grow significantly, reaching 6500 USD Million by 2035 from a base of 2500 USD Million in 2024.

    Key Market Trends & Highlights

    US Needle Free Diabetes Care Key Trends and Highlights

    • The market is valued at 2500 USD Million in 2024 and is expected to expand to 6500 USD Million by 2035.
    • The compound annual growth rate (CAGR) for the market is projected at 9.07% from 2025 to 2035.
    • This growth trajectory indicates a robust demand for innovative diabetes management solutions in the US.
    • Growing adoption of needle-free technology due to patient preference for less invasive procedures is a major market driver.

    Market Size & Forecast

    2024 Market Size 2500 (USD Million)
    2035 Market Size 6500 (USD Million)
    CAGR (2025 - 2035) 9.07%

    Major Players

    Apple Inc (US), Microsoft Corp (US), Amazon.com Inc (US), Alphabet Inc (US), Berkshire Hathaway Inc (US), Meta Platforms Inc (US), Tesla Inc (US), Johnson & Johnson (US), Visa Inc (US), Procter & Gamble Co (US)

    US Needle free diabetes care Market Trends

    US Needle free diabetes care Market Drivers

    Market Segment Insights

    Regional Insights

    Key Companies in the US Needle free diabetes care Market market include

    Industry Developments

    Market Segmentation

    Report Scope

     
    Report Attribute/Metric Source: Details
    MARKET SIZE 2018 1.42(USD Billion)
    MARKET SIZE 2024 1.5(USD Billion)
    MARKET SIZE 2035 3.2(USD Billion)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 7.131% (2025 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    MARKET FORECAST PERIOD 2025 - 2035
    HISTORICAL DATA 2019 - 2024
    MARKET FORECAST UNITS USD Billion
    KEY COMPANIES PROFILED AstraZeneca, Merck, Eli Lilly, Medtronic, Dexcom, Boehringer Ingelheim, Novo Nordisk, Insulet, Johnson and Johnson, Amgen, Roche, Tandem Diabetes Care, Sanofi, Abbott, GSK
    SEGMENTS COVERED Type, Test, Devices, Treatment
    KEY MARKET OPPORTUNITIES Telehealth diabetes management solutions, Continuous glucose monitoring technology, Personalized diabetes treatment plans, Education and support services expansion, Digital health apps for self-management
    KEY MARKET DYNAMICS rising diabetes prevalence, increasing healthcare costs, advancements in treatment technologies, growing demand for remote monitoring, government initiatives for diabetes management
    COUNTRIES COVERED US

    Market Highlights

    Author
    Garvit Vyas
    Analyst

    Explore the profile of Garvit Vyas, one of our esteemed authors at Market Research Future, and access their expert research contributions in the field of market research and industry analysis

    Get In Touch
    Leave a Comment

    FAQs

    1. EXECUTIVE SUMMARY
    2. Market
    3. Overview
    4. Key Findings
    5. Market Segmentation
    6. Competitive Landscape
    7. Challenges
    8. and Opportunities
    9. Future Outlook
    10. MARKET INTRODUCTION
    11. Definition
    12. Scope of the study
    13. Research Objective
    14. Assumption
    15. Limitations
    16. RESEARCH
    17. METHODOLOGY
    18. Overview
    19. Data
    20. Mining
    21. Secondary Research
    22. Primary
    23. Research
    24. Primary Interviews and Information Gathering
    25. Process
    26. Breakdown of Primary Respondents
    27. Forecasting
    28. Model
    29. Market Size Estimation
    30. Bottom-Up
    31. Approach
    32. Top-Down Approach
    33. Data
    34. Triangulation
    35. Validation
    36. MARKET
    37. DYNAMICS
    38. Overview
    39. Drivers
    40. Restraints
    41. Opportunities
    42. MARKET FACTOR ANALYSIS
    43. Value chain Analysis
    44. Porter's
    45. Five Forces Analysis
    46. Bargaining Power of Suppliers
    47. Bargaining
    48. Power of Buyers
    49. Threat of New Entrants
    50. Threat
    51. of Substitutes
    52. Intensity of Rivalry
    53. COVID-19
    54. Impact Analysis
    55. Market Impact Analysis
    56. Regional
    57. Impact
    58. Opportunity and Threat Analysis
    59. US
    60. Diabetes Market, BY Type (USD Billion)
    61. Type
    62. Type 2
    63. Gestational diabetes
    64. US
    65. Diabetes Market, BY Test (USD Billion)
    66. Random
    67. blood sugar test
    68. Fasting blood sugar test
    69. Oral
    70. glucose tolerance test
    71. Initial glucose challenge test
    72. others
    73. US
    74. Diabetes Market, BY Devices (USD Billion)
    75. Blood
    76. glucose monitoring devices
    77. Diabetes management devices
    78. others
    79. US
    80. Diabetes Market, BY Treatment (USD Billion)
    81. Medications
    82. Insulin
    83. therapy
    84. Transplantation
    85. Bariatric
    86. surgery
    87. others
    88. Competitive Landscape
    89. Overview
    90. Competitive
    91. Analysis
    92. Market share Analysis
    93. Major
    94. Growth Strategy in the Diabetes Market
    95. Competitive Benchmarking
    96. Leading
    97. Players in Terms of Number of Developments in the Diabetes Market
    98. Key
    99. developments and growth strategies
    100. New Product Launch/Service
    101. Deployment
    102. Merger & Acquisitions
    103. Joint
    104. Ventures
    105. Major Players Financial Matrix
    106. Sales
    107. and Operating Income
    108. Major Players R&D Expenditure.
    109. Company
    110. Profiles
    111. AstraZeneca
    112. Financial
    113. Overview
    114. Products Offered
    115. Key
    116. Developments
    117. SWOT Analysis
    118. Key
    119. Strategies
    120. Merck
    121. Financial
    122. Overview
    123. Products Offered
    124. Key
    125. Developments
    126. SWOT Analysis
    127. Key
    128. Strategies
    129. Eli Lilly
    130. Financial
    131. Overview
    132. Products Offered
    133. Key
    134. Developments
    135. SWOT Analysis
    136. Key
    137. Strategies
    138. Medtronic
    139. Financial
    140. Overview
    141. Products Offered
    142. Key
    143. Developments
    144. SWOT Analysis
    145. Key
    146. Strategies
    147. Dexcom
    148. Financial
    149. Overview
    150. Products Offered
    151. Key
    152. Developments
    153. SWOT Analysis
    154. Key
    155. Strategies
    156. Boehringer Ingelheim
    157. Financial
    158. Overview
    159. Products Offered
    160. Key
    161. Developments
    162. SWOT Analysis
    163. Key
    164. Strategies
    165. Novo Nordisk
    166. Financial
    167. Overview
    168. Products Offered
    169. Key
    170. Developments
    171. SWOT Analysis
    172. Key
    173. Strategies
    174. Insulet
    175. Financial
    176. Overview
    177. Products Offered
    178. Key
    179. Developments
    180. SWOT Analysis
    181. Key
    182. Strategies
    183. Johnson and Johnson
    184. Financial
    185. Overview
    186. Products Offered
    187. Key
    188. Developments
    189. SWOT Analysis
    190. Key
    191. Strategies
    192. Amgen
    193. Financial
    194. Overview
    195. Products Offered
    196. Key
    197. Developments
    198. SWOT Analysis
    199. Key
    200. Strategies
    201. Roche
    202. Financial
    203. Overview
    204. Products Offered
    205. Key
    206. Developments
    207. SWOT Analysis
    208. Key
    209. Strategies
    210. Tandem Diabetes Care
    211. Financial
    212. Overview
    213. Products Offered
    214. Key
    215. Developments
    216. SWOT Analysis
    217. Key
    218. Strategies
    219. Sanofi
    220. Financial
    221. Overview
    222. Products Offered
    223. Key
    224. Developments
    225. SWOT Analysis
    226. Key
    227. Strategies
    228. Abbott
    229. Financial
    230. Overview
    231. Products Offered
    232. Key
    233. Developments
    234. SWOT Analysis
    235. Key
    236. Strategies
    237. GSK
    238. Financial
    239. Overview
    240. Products Offered
    241. Key
    242. Developments
    243. SWOT Analysis
    244. Key
    245. Strategies
    246. References
    247. Related
    248. Reports
    249. LIST
    250. OF ASSUMPTIONS
    251. US Diabetes Market SIZE ESTIMATES &
    252. FORECAST, BY TYPE, 2019-2035 (USD Billions)
    253. US Diabetes
    254. Market SIZE ESTIMATES & FORECAST, BY TEST, 2019-2035 (USD Billions)
    255. US
    256. Diabetes Market SIZE ESTIMATES & FORECAST, BY DEVICES, 2019-2035 (USD Billions)
    257. US
    258. Diabetes Market SIZE ESTIMATES & FORECAST, BY TREATMENT, 2019-2035 (USD Billions)
    259. PRODUCT
    260. LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
    261. ACQUISITION/PARTNERSHIP
    262. LIST
    263. Of figures
    264. MARKET SYNOPSIS
    265. US
    266. DIABETES MARKET ANALYSIS BY TYPE
    267. US DIABETES MARKET ANALYSIS
    268. BY TEST
    269. US DIABETES MARKET ANALYSIS BY DEVICES
    270. US
    271. DIABETES MARKET ANALYSIS BY TREATMENT
    272. KEY BUYING CRITERIA
    273. OF DIABETES MARKET
    274. RESEARCH PROCESS OF MRFR
    275. DRO
    276. ANALYSIS OF DIABETES MARKET
    277. DRIVERS IMPACT ANALYSIS:
    278. DIABETES MARKET
    279. RESTRAINTS IMPACT ANALYSIS: DIABETES
    280. MARKET
    281. SUPPLY / VALUE CHAIN: DIABETES MARKET
    282. DIABETES
    283. MARKET, BY TYPE, 2025 (% SHARE)
    284. DIABETES MARKET, BY TYPE,
    285. TO 2035 (USD Billions)
    286. DIABETES MARKET, BY TEST,
    287. (% SHARE)
    288. DIABETES MARKET, BY TEST, 2019 TO 2035
    289. (USD Billions)
    290. DIABETES MARKET, BY DEVICES, 2025 (% SHARE)
    291. DIABETES
    292. MARKET, BY DEVICES, 2019 TO 2035 (USD Billions)
    293. DIABETES
    294. MARKET, BY TREATMENT, 2025 (% SHARE)
    295. DIABETES MARKET,
    296. BY TREATMENT, 2019 TO 2035 (USD Billions)
    297. BENCHMARKING
    298. OF MAJOR COMPETITORS

    US Diabetes Market Segmentation

    • Diabetes Market By Type (USD Billion, 2019-2035)

      • Type 1
      • Type 2
      • Gestational diabetes

     

    • Diabetes Market By Test (USD Billion, 2019-2035)

      • Random blood sugar test
      • Fasting blood sugar test
      • Oral glucose tolerance test
      • Initial glucose challenge test
      • others

     

    • Diabetes Market By Devices (USD Billion, 2019-2035)

      • Blood glucose monitoring devices
      • Diabetes management devices
      • others

     

    • Diabetes Market By Treatment (USD Billion, 2019-2035)

      • Medications
      • Insulin therapy
      • Transplantation
      • Bariatric surgery
      • others

     

     

     

     

     

     

    Report Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Related Reports

    No regional reports available for this market.

    No country-specific reports available for this market.

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials

    Global Magnesium Sulfate Market – Forecast till 2027